This symposium aims to clarify the ways to achieve regulatory acceptance of New Approach Methodologies (NAMs) by addressing the major obstacles to their implementation.
The event seeks to bridge the gap between in vitro and in silico model developers, end-users, and regulatory bodies, fostering a collaborative environment to streamline the adoption of these advanced methodologies that provide alternatives to animal-based research.
It will highlight practical case studies showcasing the successful integration of NAMs in clinical practice and drug development, featuring insights from biotech companies, clinics, and the pharmaceutical industry. Participants will learn key success factors for turning innovation into impactful applications and achieving NAMs validation.
Program
Session 1: Implementing NAMs in clinics: diagnostics and personalized medicine applications
Session 2: Implementing NAMs in drug discovery and development
Schanzeneckstrasse 1, 3012 Bern, Switzerland
Biotechnet Switzerland c/o FHNW School of Life Sciences, Hofackerstrasse 30, 4132 Muttenz, Switzerland
Copyright 2025, Raskin Apps and Biotechnet